Pathophysiology of Peritoneal Mesothelioma Peritoneal mesothelioma is a rare and aggressive cancer that affects the peritoneum, a thin membrane that lines the inside of the abdomen and covers most of the abdominal organs. It is most commonly caused by exposure to asbestos fibers. Pathophysiology The pathophysiology of peritoneal mesothelioma is complex and not fully understood. […]
Category: Oncology
Advances in Mesothelioma Therapy Mesothelioma is a rare type of cancer that is caused by exposure to asbestos. While there is no cure for mesothelioma, recent advancements in treatment have significantly improved outcomes for patients. Here are some of the most recent and promising treatments for mesothelioma: 1. Chemotherapy: Chemotherapy remains a cornerstone of mesothelioma […]
Mesothelioma Laws and Compensation In many jurisdictions, individuals diagnosed with mesothelioma may be eligible for compensation. This compensation can come from several sources, including: Product Liability: If the asbestos exposure occurred due to a defective product, the manufacturer or distributor may be liable. Workplace Exposure: If the exposure happened on the job, the employer or […]
Vemurafenib treats a specific type of melanoma, the most serious form of skin cancer, as a targeted therapy medication. It works by targeting a mutated gene called B R A F, which is found in many melanoma cells. How Vemurafenib Works: B R A F Mutation: In certain types of melanomas, the B R A […]
Pericardial Mesothelioma (Symptoms) Pericardial mesothelioma is a rare type of cancer that develops in the pericardium, a thin, double-layered sac that surrounds the heart. This type of mesothelioma is less common than pleural mesothelioma, which affects the tissue lining the lungs and chest wall. Symptoms of pericardial mesothelioma often include: Chest pain: This can be […]
Pralsetinib in Geriatric Patients: A Brief Overview Pralsetinib is a targeted cancer medication used to treat certain types of non-small cell lung cancer (NSCLC). While specific data on the use of pralsetinib in geriatric patients may be limited, here’s a general overview of factors to consider: Factors to Consider for Geriatric Use Age-Related Physiological Changes: […]